BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ: BMRN · IEX Real-Time Price · USD
80.70
-1.43 (-1.74%)
Apr 30, 2024, 3:44 PM EDT - Market open
BioMarin Pharmaceutical Analyst Ratings
Total Analysts
21
Consensus Rating
Buy
Price Target
$107.15
Upside
+32.78%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Maintains $115 → $112 | Buy | Maintains | $115 → $112 | +38.79% | Apr 26, 2024 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $91 → $89 | Hold | Maintains | $91 → $89 | +10.29% | Apr 26, 2024 |
| Citigroup | Citigroup | Hold Maintains $94 → $91 | Hold | Maintains | $94 → $91 | +12.76% | Apr 25, 2024 |
| Scotiabank | Scotiabank | Hold Maintains $83 → $85 | Hold | Maintains | $83 → $85 | +5.33% | Apr 25, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $110 | Buy | Reiterates | $110 | +36.31% | Apr 25, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $100 → $110 | Buy | Maintains | $100 → $110 | +36.31% | Apr 25, 2024 |
| Canaccord Genuity | Canaccord Genuity | Hold Reiterates $91 | Hold | Reiterates | $91 | +12.76% | Feb 29, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $115 → $107 | Buy | Maintains | $115 → $107 | +32.59% | Feb 23, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $100 | Buy | Reiterates | $100 | +23.92% | Feb 23, 2024 |
| RBC Capital | RBC Capital | Hold Reiterates $100 | Hold | Reiterates | $100 | +23.92% | Feb 23, 2024 |
| Baird | Baird | Buy Maintains $127 → $104 | Buy | Maintains | $127 → $104 | +28.87% | Jan 30, 2024 |
| Stifel | Stifel | Strong Buy Reiterates $101 | Strong Buy | Reiterates | $101 | +25.15% | Dec 21, 2023 |
| RBC Capital | RBC Capital | Hold Reiterates $100 | Hold | Reiterates | $100 | +23.92% | Nov 7, 2023 |
| BMO Capital | BMO Capital | Buy Maintains $102 → $100 | Buy | Maintains | $102 → $100 | +23.92% | Nov 3, 2023 |
| Piper Sandler | Piper Sandler | Buy Maintains $125 → $115 | Buy | Maintains | $125 → $115 | +42.50% | Nov 2, 2023 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $125 → $117 | Buy | Maintains | $125 → $117 | +44.98% | Nov 2, 2023 |
| Barclays | Barclays | Buy Maintains $125 → $111 | Buy | Maintains | $125 → $111 | +37.55% | Nov 2, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $120 → $100 | Buy | Maintains | $120 → $100 | +23.92% | Nov 2, 2023 |
| Bernstein | Bernstein | Sell → Hold Upgrades $82 | Sell → Hold | Upgrades | $82 | +1.61% | Oct 23, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $120 | Buy | Reiterates | $120 | +48.70% | Oct 16, 2023 |
| Raymond James | Raymond James | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Sep 28, 2023 |